Skip to main content

Table 1 Demographic and baseline characteristics

From: A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer

Variable

N

Missing

Aza

Rom

Aza + Rom

Overall

p

Histology, n (%)

27

0

    

1.00

 Adenocarcinoma

  

7 (100.0)

10 (100.0)

10 (100.0)

27 (100.0)

 

Age, median (min, max)

27

0

57.0 (48.0, 69.0)

49.0 (46.0, 67.0)

58.5 (40.0, 68.0)

57.0 (40.0, 69.0)

0.36

Gender, n (%)

27

0

    

0.39

 Male

  

3 (42.9)

7 (70.0)

4 (40.0)

14 (51.9)

 

 Female

  

4 (57.1)

3 (30.0)

6 (60.0)

13 (48.1)

 

Race, n (%)

26

1

    

0.59

 White

  

6 (85.7)

5 (55.6)

6 (60.0)

17 (65.4)

 

 Black or AA

  

1 (14.3)

3 (33.3)

4 (40.0)

8 (30.8)

 

 Asian

  

0 (0.0)

1 (11.1)

0 (0.0)

1 (3.8)

 

Ethnicity, n (%)

27

0

    

1.00

 Non-Hispanic

  

7 (100.0)

9 (90.0)

10 (100.0)

26 (96.3)

 

 Hispanic or Latino

  

0 (0.0)

1 (10.0)

0 (0.0)

1 (3.7)

 

Nodal status, n (%)

22

5

    

0.10

 Negative

  

1 (16.7)

0 (0.0)

3 (42.9)

4 (18.2)

 

 Positive

  

5 (83.3)

9 (100.0)

4 (57.1)

18 (81.8)

 

LN total, median (min, max)

27

0

21.0 (0.0, 28.0)

16.5 (0.0, 51.0)

14.5 (0.0, 62.0)

19.0 (0.0, 62.0)

0.83

Margin, n (%)

23

4

    

1.00

 Negative

  

5 (83.3)

8 (80.0)

6 (85.7)

19 (82.6)

 

 Positive

  

1 (16.7)

2 (20.0)

1 (14.3)

4 (17.4)

 

PNI, n (%)

16

11

    

0.66

 Absent

  

2 (66.7)

2 (25.0)

2 (40.0)

6 (37.5)

 

 Present

  

1 (33.3)

6 (75.0)

3 (60.0)

10 (62.5)

 

LVI, n (%)

17

10

    

1.00

 Absent

  

1 (25.0)

2 (33.3)

3 (42.9)

6 (35.3)

 

 Present

  

3 (75.0)

4 (66.7)

4 (57.1)

11 (64.7)

 

Site, n (%)

27

0

    

0.38

 Right

  

1 (14.3)

3 (30.0)

5 (50.0)

9 (33.3)

 

 Transverse

  

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 

 Left

  

5 (71.4)

4 (40.0)

2 (20.0)

11 (40.7)

 

 Rectum

  

1 (14.3)

3 (30.0)

3 (30.0)

7 (25.9)

 

Grade, n (%)

24

3

    

0.74

 Well

  

0 (0.0)

2 (20.0)

0 (0.0)

2 (8.3)

 

 Moderate

  

5 (83.3)

7 (70.0)

6 (75.0)

18 (75.0)

 

 Poor

  

1 (16.7)

1 (10.0)

2 (25.0)

4 (16.7)

 

CEA, median (min, max)

27

0

10.2 (1.7, 1477.0)

97.2 (4.9, 415.4)

42.5 (4.1, 1033.3)

43.0 (1.7, 1477.0)

0.66

ANC, median (min, max)

27

0

3.75 (1.89, 19.69)

4.87 (2.90, 8.20)

3.20 (2.31, 5.81)

3.66 (1.89, 19.69)

0.25

ALC, median (min, max)

27

0

1.88 (0.72, 2.71)

1.37 (1.00, 2.50)

1.29 (0.49, 2.29)

1.31 (0.49, 2.71)

0.55

NLR, median (min, max)

27

0

2.46 (1.01, 8.56)

3.51 (1.57, 7.70)

2.51 (1.74, 6.96)

2.74 (1.01, 8.56)

0.81